CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- 4 Open-market sale EVP, Investments & CLO sold 40,000 shares at an average $43.14 ($1,725,567)
- 4 Open-market sale Director sold 120,000 shares at $42.33 ($5,079,924)
- 4 Open-market sale EVP, Investments & CLO sold 50,000 shares at an average $43.85 ($2,192,613)
- 4 Open-market sale EVP & CFO sold 24,500 shares at $43.47 ($1,065,013)
- 4 Open-market sale EVP & CFO sold 5,500 shares at $43.06 ($236,846)
- 4 Grant or award Director acquired 913 shares (grant or award)
- 4 Grant or award Director acquired 913 shares (grant or award)
- 4 Open-market sale EVP & Chief Scientific Officer sold 100,000 shares at $41.23 ($4,122,670)
- 4 Open-market sale Director sold 32,593 shares at $41.05 ($1,337,943)
- 4 Open-market sale Director sold 211,380 shares at $41.17 ($8,702,113)
- 4 Open-market sale Director sold 523,842 shares at an average $41.07 ($21,516,554)
- 4 Open-market sale 10% owner sold 267,815 shares at $41.02 ($10,985,798)
- 4 Open-market sale Director sold 387,171 shares at an average $41.59 ($16,101,817)
- 4 Open-market sale 10% owner sold 387,171 shares at an average $41.59 ($16,101,934)
- 4 Open-market sale Director sold 345,014 shares at an average $42.38 ($14,622,925)
- 4 Open-market sale 10% owner sold 345,014 shares at an average $42.38 ($14,623,052)
- 4 Open-market sale Director sold 100,000 shares at an average $42.30 ($4,230,387)
- 4 Open-market sale Director sold 499,500 shares at an average $42.70 ($21,327,337)
- 4 Open-market sale 10% owner sold 498,006 shares at an average $42.70 ($21,262,534)
- 4 Open-market sale 10% owner sold 1,994 shares at $44.00 ($87,736)
Page 10 of 18 · 342 filings